Intervention Review

Non-steroid agents for idiopathic pulmonary fibrosis

  1. Paolo Spagnolo2,
  2. Cinzia Del Giovane3,
  3. Fabrizio Luppi4,
  4. Stefania Cerri2,
  5. Sara Balduzzi3,
  6. E. Haydn Walters5,
  7. Roberto D'Amico3,
  8. Luca Richeldi2,*

Editorial Group: Cochrane Airways Group

Published Online: 8 SEP 2010

Assessed as up-to-date: 26 JUL 2010

DOI: 10.1002/14651858.CD003134.pub2


How to Cite

Spagnolo P, Del Giovane C, Luppi F, Cerri S, Balduzzi S, Walters EH, D'Amico R, Richeldi L. Non-steroid agents for idiopathic pulmonary fibrosis. Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD003134. DOI: 10.1002/14651858.CD003134.pub2.

Author Information

  1. 2

    University of Modena and Reggio Emilia, Center for Rare Lung Disease, University of Modena and Reggio Emilia, Modena Italy and Respiratory Disease Section, Department of Oncology, Hematology and Respiratory Disease, Modena, Italy

  2. 3

    University of Modena and Reggio Emilia, Statistics Unit, Department of Oncology, Hematology and Respiratory Disease, Modena, Italy

  3. 4

    Center for Rare Lung Disease, University of Modena and Reggio Emilia, Modena Italy and Respiratory Disease Section, Department of Oncology, Hematology and Respiratory Disease Azienda Ospedaliero-Universitaria di Modena, Modena, Italy

  4. 5

    University of Tasmania, Menzies Research Institute, Hobart, Tasmania, Australia

*Luca Richeldi, Center for Rare Lung Disease, University of Modena and Reggio Emilia, Via del Pozzo, 71, Modena, 41100, Italy. luca.richeldi@unimore.it.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 8 SEP 2010

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Dominique Valeyre, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Talmadge E. King, Jonathan A. Leff, Paul W. Noble, Steven A. Sahn, Roland M. Bois, Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis, Respirology, 2014, 19, 5
  2. 2
    Edward C. F. Wilson, Ludmila Shulgina, Anthony P. Cahn, Edwin R. Chilvers, Helen Parfrey, Allan B. Clark, Orion P. Twentyman, Andrew M. Wilson, Treating Idiopathic Pulmonary Fibrosis with the Addition of Co-Trimoxazole: An Economic Evaluation Alongside a Randomised Controlled Trial, PharmacoEconomics, 2014, 32, 1, 87

    CrossRef

  3. 3
    Hiroyuki Taniguchi, Yasuhiro Kondoh, Combination Therapies Targeting Multiple Pathways in idiopathic pulmonary fibrosis (IPF), Internal Medicine, 2013, 52, 22, 2481

    CrossRef

  4. 4
    Paolo Spagnolo, Roland M du Bois, Vincent Cottin, Rare lung disease and orphan drug development, The Lancet Respiratory Medicine, 2013, 1, 6, 479

    CrossRef

  5. 5
    Francesco Boin, Fredrick M. Wigley, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  6. 6
    J. Ancochea, C. Valenzuela, Diagnóstico y tratamiento de la fibrosis pulmonar idiopática, Medicine - Programa de Formación Médica Continuada Acreditado, 2012, 11, 23, 1389

    CrossRef

  7. 7
    Aryeh Fischer, Roland du Bois, Interstitial lung disease in connective tissue disorders, The Lancet, 2012, 380, 9842, 689

    CrossRef

  8. 8
    Stefania Cerri, Paolo Spagnolo, Fabrizio Luppi, Luca Richeldi, Management of Idiopathic Pulmonary Fibrosis, Clinics in Chest Medicine, 2012, 33, 1, 85

    CrossRef

  9. You have free access to this content9
    Ole Hilberg, Ulf Simonsen, Roland du Bois, Elisabeth Bendstrup, Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis, The Clinical Respiratory Journal, 2012, 6, 3
  10. 10
    Jian Gao, Li-jie Feng, Yan Huang, Ping Li, Du-juan Xu, Jun Li, Qiang Wu, Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodelling, Journal of Pharmacy and Pharmacology, 2012, 64, 6
  11. You have free access to this content11
    Luca Richeldi, Treating idiopathic pulmonary fibrosis: current opportunities and future challenges, The Clinical Respiratory Journal, 2012, 6, 3
  12. 12
    Kevin O'Brien, James Troendle, Bernadette R. Gochuico, Thomas C. Markello, Jose Salas, Hilda Cardona, Jianhua Yao, Isa Bernardini, Richard Hess, William A. Gahl, Pirfenidone for the treatment of Hermansky–Pudlak syndrome pulmonary fibrosis, Molecular Genetics and Metabolism, 2011, 103, 2, 128

    CrossRef

  13. 13
    Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg, Dominique Valeyre, Roland M du Bois, Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials, The Lancet, 2011, 377, 9779, 1760

    CrossRef